ArticleHuman vaccines & immunotherapeutics2018

Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea.

Min-Joo Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.